The model parameters identified for the acarbose group were as follows:
the change from baseline in HbA1c was -0.563%;
the change from baseline in systolic blood pressure was -2.689 mmHg;
the change from baseline in total cholesterol was -3.717 mg/dL;
the change from baseline in low-density lipids was -3.596 mg/dL;
the change from baseline in high-density lipids was 0.837 mg/dL;
the change from baseline in triglycerides was -20.396 mg/dL; and
the change from baseline in BMI was -0.395 kg/m2.
The model parameters identified for the placebo group were as follows:
the change from baseline in HbA1c was 0.01%;
the change from baseline in systolic blood pressure was -0.682 mmHg;
the change from baseline in total cholesterol was -2.055 mg/dL;
the change from baseline in low-density lipids was -5.224 mg/dL;
the change from baseline in high-density lipids was 1.724 mg/dL;
the change from baseline in triglycerides was 3.762 mg/dL; and
the change from baseline in BMI was -0.277 kg/m2.